ArticleEndoscopy international open2026
Off-Label Biliary Stents for Refractory Anastomotic Strictures and Leaks after Esophageal Atresia Repair in Infants.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anastomotic strictures and leaks are frequent complications following the surgical repair of esophageal atresia, with a subset of patients developing refractory disease despite repeated dilations. This case series evaluates the preliminary feasibility and the outcomes of using off-label, fully covered, self-expanding, metal biliary stents in infants with refractory anastomotic strictures or leaks. Six infants treated at a tertiary referral center between 2021 and 2025 underwent endoscopic placement of fully covered self-expanding metal biliary stents. Technical success in stent placement and removal was achieved in all patients (100%). Clinical success was observed in 83.3% of patients; specifically, complete sealing of leaks and perforations was achieved in 100% of cases, while sustained luminal patency was observed in half of the isolated refractory strictures. One patient with a long-segment stricture required subsequent surgical revision. No major adverse events were identified during a median follow-up of 2.75 years. These preliminary findings suggest that biliary stents may represent a feasible rescue option for managing complex postoperative esophageal atresia complications in infants when specialized pediatric devices are unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.